药物分析杂志2024,Vol.44Issue(2) :280-289.DOI:10.16155/j.0254-1793.2024.02.11

ICP-MS法测定盐酸阿芬太尼注射液中25种元素杂质的含量

Determination of 25 elements impurities in alfentanil hydrochloride injection by ICP-MS

高梓真 李磊 许如玲 许向阳
药物分析杂志2024,Vol.44Issue(2) :280-289.DOI:10.16155/j.0254-1793.2024.02.11

ICP-MS法测定盐酸阿芬太尼注射液中25种元素杂质的含量

Determination of 25 elements impurities in alfentanil hydrochloride injection by ICP-MS

高梓真 1李磊 1许如玲 1许向阳1
扫码查看

作者信息

  • 1. 江苏恩华药业股份有限公司,徐州 221100
  • 折叠

摘要

目的:建立电感耦合等离子体质谱法(ICP-MS),测定盐酸阿芬太尼注射液中25种具有潜在风险的元素杂质的含量.方法:采用Agilent 7800 ICP-MS电感耦合等离子体质谱仪,运用常规调谐模式,射频功率1 550 W,等离子气体流量15 L·min-1,通过外标方式消除基质效应,样品稀释直接进样测定.结果:该方法能同时测定25种元素杂质含量,其线性关系良好(r>0.99),重复性试验的RSD≤10%(n=6),回收率在80.0%~120.0%(n=9),均满足方法学验证的要求.结论:盐酸阿芬太尼注射液元素杂质含量均低于ICH·Q3D规定限度的30%,不会给药品带来安全性风险,本法为其他相似药品元素杂质的质量控制和风险评估提供了参考.

Abstract

Objective:To establish an inductively coupled plasma mass spectrometry(ICP-MS)method for the determination of 25 potentially risky elemental impurities in alfentanil hydrochloride injection.Methods:The Agi-lent 7800 ICP-MS inductively coupled plasma mass spectrometer was used,the conventional tuning mode was used,the RF power was 1 550 W,the plasma gas flow rate was 15 L·min-1,the matrix effect was eliminated by external standard,and the sample was diluted for direct injection.Results:The method can simultaneously deter-mine the content of 25 kinds of elemental impurities,and its linear relationship was good(r>0.99).The RSD of the repeatability test was ≤10%(n=6),and the recovery rate was 80.0%-120.0%(n=9),all of which met the requirements of methodological validation.Conclusion:The content of elemental impurities in alfentanil hydro-chloride injection is lower than 30%of the limit specified in ICH·Q3D,which will not bring safety risks to the drug,providing a reference for the quality control and risk assessment of elemental impurities in other similar drugs.

关键词

盐酸阿芬太尼注射液/电感耦合等离子体质谱法/元素杂质/方法学验证/含量测定/杂质限度

Key words

alfentanil hydrochloride injection/inductively coupled plasma mass spectrometry/element impurities/methodology validation/content determination/impurity limit

引用本文复制引用

基金项目

江苏省中枢神经药物研究重点实验室资助项目(BM2019004)

出版年

2024
药物分析杂志
中国药学会

药物分析杂志

CSTPCDCSCD北大核心
影响因子:1.039
ISSN:0254-1793
参考文献量19
段落导航相关论文